Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melatonin receptor type 1A (MT1), encoded by the MTNR1A gene, is a high-affinity G protein-coupled receptor (GPCR) that plays a fundamental role in regulating circadian rhythms, sleep-wake cycles, and seasonal reproductive processes. It is primarily localized in the suprachiasmatic nucleus (SCN) of the hypothalamus, the master pacemaker of the mammalian circadian system, as well as the pituitary gland and retina. Upon activation by its endogenous ligand melatonin or synthetic agonists, MT1 couples to Gi/o proteins to inhibit adenylate cyclase activity, thereby decreasing intracellular cyclic AMP (cAMP) levels and suppressing neuronal firing in the SCN to promote sleep. Dysregulation of MT1 signaling is implicated in sleep disorders such as insomnia and non-24-hour sleep-wake disorder, as well as major depressive disorder and metabolic conditions like type 2 diabetes. Therapeutic targeting of MT1 with agonists like ramelteon, tasimelteon, and agomelatine is widely utilized to facilitate sleep onset, resynchronize circadian rhythms, and manage depressive symptoms.
Agonism of the G protein-coupled receptor, leading to Gi/o protein coupling, inhibition of adenylate cyclase, and reduction of intracellular cAMP levels.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melatonin receptor type 1A (MT1) (MT1).